PGP9.5 methylation as a marker for metastatic colorectal cancer

Anticancer Research

Volumn 28, Issue 5 A, 2008, Pages 2697-2700

  Mizukami, Hiroki ^a   Shirahata, Atsushi ^a   Goto, Tetsuhiro ^a   Sakata, Makiko ^a   Saito, Mitsuo ^a   Ishibashi, Kazuyoshi ^a   Kigawa, Gaku ^a   Nemoto, Hiroshi ^a   Sanada, Yutaka ^a   Hibi, Kenji ^a  

^a SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

Author keywords

Colorectal cancer; Marker; PGP9.5; Quantitative methylation specific PCR

Indexed keywords

GENE PRODUCT; PROTEIN GENE PRODUCT 9.5; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN METHYLATION;

AGED; COLORECTAL NEOPLASMS; DNA METHYLATION; FEMALE; GENETIC MARKERS; HUMANS; MALE; MIDDLE AGED; UBIQUITIN THIOLESTERASE;

EID: 55749091975     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Bos JL, Fearon ER, Hamilton SR, Verlaan-de Vries M, van Boom JH, van der Eb AJ and Vogelstein B: Prevalence of ras gene mutations in human colorectal cancers. Nature 327: 293-297, 1987.
2. Nishisho I, Nakamura Y, Miyoshi Y, Miki Y, Ando H, Horii A, Koyama K, Utsunomiya J, Baba S, Hedge P, Markham A, Krush AJ, Petersen G, Hamilton SR, Nilbert MC, Levy DB, Bryan TM, Preesinger AC, Smith KJ, Su LK, Kinzler KW and Vogelsteen B: Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 253: 665-669, 1991.
3. Baker SJ, Markowitz S, Fearon ER, Willson JK and Vogelstein B: Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249: 912-915, 1990.
4. Hibi K, Nakamura H, Hirai A, Fujikake Y, Kasai Y, Akiyama S, Ito K and Takagi H: Loss of H19 imprinting in esophageal cancer. Cancer Res 56: 480-482, 1996.
5. Hibi K, Taguchi M, Nakamura H, Hirai A, Fujikake Y, Matsui T, Kasai Y, Akiyama S, Ito K and Takagi H: Alternative splicing of the FHIT gene in colorectal cancer. Jpn J Cancer Res 88: 385-388, 1997.
6. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM and Bos JL: Genetic alterations during colorectal-tumor development. N Engl J Med 319: 525-532, 1988.
7. Lee YM, Lee JY, Kim MJ, Bae HI, Park JY, Kim SG and Kim DS: Hypomethylation of the protein gene product 9.5 promoter region in gallbladder cancer and its relationship with clinicopathological features. Cancer Sci 97: 1205-1210, 2006.
8. Yamazaki T, Hibi K, Takase T, Tezel E, Nakayama H, Kasai Y, Ito K, Akiyama S, Nagasaka T and Nakao A: PGP9.5 as a marker for invasive colorectal cancer. Clin Cancer Res 8: 192-195, 2002.
9. Hibi K, Nakayama H, Koike M, Kasai Y, Ito K, Akiyama S and Nakao A: Colorectal cancers with both p!6 and p14 methylation show invasive characteristics. Jpn J Cancer Res 93: 883-887, 2002.
10. Hibi K, Sakata M, Sakuraba K, Shirahata A, Goto T, Mizukami H, Saito M, Ishibashi K, Kigawa G, Nemoto H and Sanada Y: Aberrant methylation of the HACE1 gene is frequently detected in advanced colorectal cancer. Anticancer Res 28: 1581-1584, 2008.
11. Mandelker DL, Yamashita K, Tokumaru Y, Mimori K, Howard DL, Tanaka Y, Carvalho AL, Jiang W, Park HL, Kim MS, Osada M, Mori M and Sidransky D: PGP9.5 promoter methylation is an independent prognostic factor for esophageal squamous cell carcinoma. Cancer Res 65: 4963-4968, 2005.
12. Greenlee RT, Murray T, Bolden S and Wingo PA: Cancer statistics, 2000. CA Cancer J Clin 50: 7-33, 2000.
13. Wilkinson KD, Lee KM, Deshpande S, Duerksen-Hughes P, Boss JM and Pohl J: The neuron-specific protein PGP9.5 is a ubiquitin hydrolase. Science 246: 670-673, 1989.
14. Day IN and Thompson RJ: Molecular cloning of cDNA coding for human PGP9.5 protein. A novel cytoplasmic marker for neurons and neuroendocrine cells. FEBS Lett 210: 157-160, 1987.
15. Hochstrasser M: Ubiquitin-dependent protein degradation. Annu Rev Genet 30: 405-439, 1996.
16. Diehl JA, Zindy F and Sherr CJ: Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway. Genes Dev 11: 957-972, 1997.
17. Tezel E, Hibi K, Nagasaka T and Nakao A: PGP9.5 as a prognostic factor in pancreatic cancer. Clin Cancer Res 6: 4764-4767, 2000.
18. Hibi K, Liu Q, Beaudry GA, Madden SL, Westra WH, Wehage SL, Yang SC, Heitmiller RF, Bertelson AH, Sidransky D and Jen J: Serial analysis of gene expression in non-small cell lung cancer. Cancer Res 58: 5690-5694, 1998.
19. Hibi K, Westra WH, Borges M, Goodman S, Sidransky D and Jen J: PGP9.5 as a candidate tumor marker for non-small cell lung cancer. Am J Pathol 155: 711-715, 1999.
20. Hibi K, Robinson CR, Booker S, Wu L, Hamilton SR, Sidransky D and Jen J: Molecular detection of genetic alterations in the serum of colorectal cancer patients. Cancer Res 58: 1405-1407, 1998.
21. Nakayama H, Hibi K, Taguchi M, Takase T, Yamazaki T, Kasai Y, Ito K, Akiyama S and Nakao A: Molecular detection of p16 promoter methylation in the serum of colorectal cancer patients. Cancer Lett 188: 115-119, 2002.